DOCSLIB.ORG

Are We Overusing IVF?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Are We Overusing IVF? ANALYSIS MEHAU KULYK/SPL MEHAU Are we overusing IVF? The indications for IVF have expanded from tubal disorders to many causes of subfertility, including “unexplained.” But with limited evidence underpinning its extended remit Esme Kamphuis and colleagues explain how the risks could outweigh the benefits ince the birth of the first baby by in Ж Read about the BMJ’s alternatives to IVF such as clomifene citrate.8 vitro fertilisation (IVF) in 1978, the Too Much Medicine campaign Another factor is that procedures are increas- technique has earned its reputation at bmj.com/too-much-medicine ingly performed in private health systems, where as a major medical breakthrough of result in overtreatment of couples who had a the focus on commercial returns has resulted in the 20th century. IVF was developed reasonable chance of conceiving naturally? Is less academic oversight of who receives treat- Sfor women with tubal disease,1 but its indica- it equally effective in these conditions? And, as ment and when.9 Amid this the indications for tions soon began to grow. In the 1990s intra- more is understood about the adverse health IVF have been expanded to include mild male cytoplasmic sperm injection was developed outcomes in IVF children can the risks of IVF subfertility, the effect of ageing on ovarian to treat couples in which the man has poor be justified for these more liberal applications? function, and unexplained subfertility where semen quality,2 which like tubal infertility pre- no absolute barrier to conception can be proved vents sperm from coming into close proximity Rising rates of IVF (table 1). And it is in these groups that use of IVF with an egg. In recent years, however, IVF has One million babies were born in the first 25 years is expanding the most. been applied to other types of subfertility such of IVF between 1978 and 2003. It took only two In the United States, the number of IVF cycles as mild male subfertility, endometriosis, and more years for the tally to reach two million in offered annually increased from 90 000 in 2000 unexplained subfertility. The birth of many 2005, with over five million estimated to have to 150 000 in 2010, but the proportion with healthy children has enhanced provider and been born by the end of 2013.3 In developed tubal problems as an indication fell from 25% to patient confidence in the safety of IVF. But countries with public health systems 2-3% of the 16%.10 In the UK the proportion of IVF cycles for does applying IVF to wider forms of infertility births each year are through IVF, rising as high tubal problems fell from 19% to 12% between as 5% in Denmark and Belgium.4 This is despite 2000 and 2011, although the number of cycles KEY MESSAGES the fact that an observational study showed that remained at around 7000 (table 1).11 The figures The scope of IVF has expanded in the last 95% of 350 couples planning a first pregnancy for unexplained subfertility tripled from 6204 to two decades to embrace a wider range of conceive within 24 months.5 19 552 cycles. Similar shifts have been reported indications, including unexplained subfertility The reasons for the rise in IVF are complex. in the Netherlands.12 The evidence underpinning the use of IVF for Women may plan to have children later and some of these newer indications is weak some are choosing to freeze their eggs.6 A lack IVF and unexplained infertility Outcomes in children conceived through IVF of confidence, among both subfertile couples The value of IVF for tubal blockage and severe seem to be poorer than in those conceived and their doctors, that conception will eventu- male factor infertility, where a live birth rate of naturally ally occur naturally can lead to access to IVF 20-30% per cycle offers the only chance of con- We need to evaluate which couples have a within two to three years of trying to conceive, ception, is not in dispute. However, the evidence reasonable chance of natural conception and the lure of new technology and access to for newer indications such as unexplained For those needing help, the effectiveness and more patient friendly IVF programmes make it subfertility is less clear. Unexplained sub- safety of IVF should be investigated afresh more appealing.7 Evidence has also undermined fertility accounts for 25% to 30% of all couples BMJ | 1 FEBRUARY 2014 | VOLUME 348 15 ANALYSIS Table 1 | Evidence of effectiveness of IVF treatment for different types of infertility and change in indications Table 2 | Potential harms of IVF in singleton between 2000 and 2011 in the United Kingdom11 pregnancies compared with natural conception No (%) of IVF cycles Odds ratio (95% CI) Reason for fertility problem Evidence of effectiveness 2000 (n=35 450) 2011 (n=60 473) Perinatal outcomes Two sided tubal pathology Effective: no chance of conception 6771 (19)* 7 470 (12%)* Preterm birth (<37 weeks)26 35 1.5 (1.5 to 1.6) 1 2 without medical assistance 26 35 Severe male infertility 9777 (28)† 19 643 (33%)† Very preterm birth (<32 weeks) 1.7 (1.5 to 1.9) 26 35 Obstructive male infertility † † Low birth weight (<2500 g) 1.7 (1.6 to 1.8) Very low birth weight (<1500g)26 1.9 (1.7 to 2.2) Anovulation 7% 6% Perinatal mortality26 1.9 (1.5 to 2.4) Unexplained subfertility IVF treatment effective in subfertility 6204 (18) 19 552 (32) Small gestational age26 1.4 (1.3 to 1.5) >4 years; no more effective than less One sided tubal pathology * * 26 36 invasive alternatives in subfertility Congenital malformations 1.7 (1.3 to 2.1) Mild male subfertility <2.5 years; effectiveness unknown for † † Long term outcomes 18 Endometriosis subfertility 2.5-4 years 886 (3) 2 550 (4) Cerebral palsy36 2.8 (1.3 to 16) 33 Poor ovarian reserve No comparative effectiveness data NA NA Generalised vascular dysfunction Increase available Advanced maternal age NA NA Diastolic/systolic blood pressure 61/109 v 59/105 (mm Hg)34 Other or mixed factors 12 691 (25) 11 252 (12) 35 Fat deposition Increase or no change * One sided and double sided tubal pathology were reported together. Fasting glucose35 Increase or no change † Severe male infertility, obstructive male infertility, and mild male subfertility reported together. pr esenting for IVF, many of whom will conceive It is not just a question of whether to intervene tiple births by requiring single embryo trans- before treatment.12-14 In a cohort of 500 Dutch in unexplained subfertility, but when. Economic fer, multiple transfer is still common in many subfertile couples with on average almost two modelling studies indicate that, in younger parts of the world, including the United States years of unexplained subfertility, 60% conceived women with no obvious cause of infertility, IVF and Asia, where multiple birth rates are 20% to naturally after the initial assessment in the fer- is not cost effective within three years of trying 30%.29 Furthermore, studies suggest that tility clinic.15 Other observational studies have to conceive.21 How- single embryo trans- confirmed natural conceptions in couples with ever, experimental fer, which involves subfertility for two to three years.16 17 and observational IVF extended embryo A Cochrane review comparing IVF with research often does culture and trans- expectant management in women without tubal not mention how long fer of a blastocyst, problems identified one trial of 51 women with couples have been try- is associated with a unexplained infertility who had been trying to ing to conceive. Forty 50-70% additional conceive for an average of four years.18 19 The five of the 71 (63%) risk of preterm birth trial reported live birth rates of 29% in women randomised trials of and congenital randomised to one cycle of IVF versus 1% in IVF in 2009 and 2010 m alformations.30-32 the expectant management group. Although did not state length LTD/SPL IMAGING MEDICAL CANE DU Concern has also this may seem like a success for IVF, the women of infertility. National The evidence for newer explanations been raised about in this trial had been trying to conceive for four fertility registries in such as unexplained subfertility is the long term health years, which is much longer than is current Sweden, Australia, less clear. Unexplained subfertility of children born practice in many countries. A randomised clini- Belgium, New Zea- accounts for 25-30% of all couples through IVF. Other- cal trial comparing intrauterine insemination land, Canada, and the wise healthy chil- and ovarian hyperstimulation with expectant United States also do not collect data on dura- dren conceived by IVF may have higher blood management in couples who had an average tion of infertility. pressure, adiposity, glucose levels, and more of two years’ unexplained subfertility found In the UK the National Institute for Health and generalised vascular dysfunction than children a pregnancy rate of 25% after six months and Care Excellence changed its recommendation conceived naturally (table 2). These effects seem 75% after three years in both groups.17 It seems regarding the timing of access to IVF in couples to be related to the IVF procedure itself rather that a short delay in treatment does not affect with unexplained infertility where the woman is than to underlying subfertility.33-36 Animal stud- ovarian reserve in such a way that more couples younger than 40 from three to two years.22 How- ies have shown epigenetic and developmental will end up childless. ever, it did not provide any references to justify abnormalities after assisted reproduction, which Another randomised trial (FASTT) in the US the threshold.
Load more

Recommended publications
  • Artificial Insemination
    Ch36-A03309.qxd 1/23/07 5:16 PM Page 539 Section 6 Infertility and Recurrent Pregnancy Loss Chapter Artificial Insemination 36 Ashok Agarwal and Shyam S. R. Allamaneni INTRODUCTION widely available, the terms homologous artificial insemination and heterologous artificial insemination were used to differentiate Artificial insemination is an assisted conception method that can these two alternative sources. However, the use of these bio- be used to alleviate infertility in selected couples. The rationale medical terms in this manner is at variance with their scientific behind the use of artificial insemination is to increase the gamete meaning, where they denote different species or organisms (as in, density near the site of fertilization.1 The effectiveness of artificial e.g., homologous and heterologous tissue grafts). insemination has been clearly established in specific subsets of In the latter half of the 20th century, the terms artificial infertile patients such as those with idiopathic infertility, infertility insemination, donor (AID) and artificial insemination, husband related to a cervical factor, or a mild male factor infertility (AIH) found common use. However, the widespread use of the (Table 36-1).2,3 An accepted advantage of artificial insemination acronym AIDS for acquired immunodeficiency syndrome resulted is that it is generally less expensive and invasive than other in the replacement of AID with therapeutic donor insemination assisted reproductive technology (ART) procedures.4 (TDI). An analogous alternative term for AIH has not evolved, This chapter provides a comprehensive description of probably in part because of the increasingly common situation indications for artificial insemination, issues to consider before where the woman’s partner is not her legal husband.
    [Show full text]
  • Unexplained Infertility
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, University of Helsinki, Finland UNEXPLAINED INFERTILITY Studies on aetiology, treatment options and obstetric outcome RITA ISAKSSON ACADEMIC DISSERTATION To be presented by permission of the Medical Faculty of the University of Helsinki for public criticism in the Auditorium of the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Haartmaninkatu 2, Helsinki, on October 18th, 2002, at 12 noon. Helsinki 2002 1 Supervised by Docent Aila Tiitinen, M.D., Ph.D. Department of Obstetrics and Gynaecology Helsinki University Central Hospital Docent Bruno Cacciatore, M.D., Ph.D. Department of Obstetrics and Gynaecology Helsinki University Central Hospital Reviewed by Docent Anne-Maria Suikkari, M.D., Ph.D. The Family Federation of Finland, Infertility Clinic, Helsinki Docent Aydin Tekay, M.D., Ph.D. Department of Obstetrics and Gynaecology Oulu University Central Hospital Offi cial opponent Docent Hannu Martikainen, M.D., Ph.D. Department of Obstetrics and Gynaecology Oulu University Central Hospital ISBN 952-91-5071-7 (print) ISBN 952-10-0712-5 (PDF) Yliopistopaino Helsinki 2002 2 To my family 3 CONTENTS LIST OF ORIGINAL PUBLICATIONS ....................................................................7 ABBREVIATIONS .................................................................................................
    [Show full text]
  • Definitions and Relevance of Unexplained Infertility in Reproductive Medicine 5
    Definitions and Relevance of Unexplained Infertility 1 in Reproductive Medicine Sandro C. Esteves, Glenn L. Schattman and Ashok Agarwal Infertility is customarily defined as the inability of a sexually infertility can result from congenital or acquired urogenital active couple with no contraception to achieve natural preg- abnormalities, urogenital tract infections, increased scrotal nancy within one year [1]. The American Society for Repro- temperature such as a consequence of varicocele, endocrine ductive Medicine (ASRM) considers infertility as a disease, disturbances, genetic abnormalities, immunological factors, which by definition is ‘‘any deviation from or interruption of lifestyle habits (e.g., obesity, smoking, and use of gonado- the normal structure or function of any part, organ, or system toxins), systemic diseases, erectile dysfunction, and incor- of the body as manifested by characteristic symptoms and rect coital habitus. Unfortunately, owed to limitations in our signs; the etiology, pathology, and prognosis may be known understanding of the events that take place during natural or unknown’’ [2, 3]. conception, and in view of the crude diagnostic tests avail- It has been estimated that 15 % of couples seek medical able to identify potential abnormalities, the cause of infertil- assistance for infertility, and the origins of the problem seem ity is not determined in nearly half of the cases. Moreover, to be equally distributed between male and female partners approximately 5 % of couples remain unwillingly childless [1]. Taking into account a global perspective and a world despite multiple interventions [1, 8, 9]. population of 7 billion people, these figures indicate that ap- Infertility of unknown origin comprises both idiopathic proximately 140 million people (2.2 %) face infertility [4, 5].
    [Show full text]
  • Male Infertility Is a Women's Health Issue—Research and Clinical
    cells Review Male Infertility is a Women’s Health Issue—Research and Clinical Evaluation of Male Infertility Is Needed Katerina A. Turner 1 , Amarnath Rambhatla 2, Samantha Schon 3, Ashok Agarwal 4 , Stephen A. Krawetz 5, James M. Dupree 6 and Tomer Avidor-Reiss 1,7,* 1 Department of Biological Sciences, University of Toledo, Toledo, OH 43606, USA; [email protected] 2 Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202, USA; [email protected] 3 Division of Reproductive Endocrinology & Infertility, Department of Obstetrics and Gynecology, University of Michigan Medical School, L4000 UH-South, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA; [email protected] 4 American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH 44195, USA; [email protected] 5 Department of Obstetrics and Gynecology, Center for Molecular Medicine and Genetics, C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA; [email protected] 6 Department of Urology and Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48019, USA; [email protected] 7 Department of Urology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USA * Correspondence: [email protected] Received: 25 February 2020; Accepted: 14 April 2020; Published: 16 April 2020 Abstract: Infertility is a devastating experience for both partners as they try to conceive. Historically,when a couple could not conceive, the woman has carried the stigma of infertility; however, men and women are just as likely to contribute to the couple’s infertility.
    [Show full text]
  • Folate, Hormones and Infertility
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 987 Folate, Hormones and Infertility Different factors affecting IVF pregnancy outcome TIINA MURTO ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-554-8919-9 UPPSALA urn:nbn:se:uu:diva-220476 2014 Dissertation presented at Uppsala University to be publicly examined in Gustavianum, Auditorium Minus, Akademigatan 3, Uppsala, Thursday, 22 May 2014 at 09:15 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in Swedish. Faculty examiner: Associate Professor Sven-Eric Olsson (Institutionen för kliniska vetenskaper, Danderyds sjukhus (KI DS)). Abstract Murto, T. 2014. Folate, Hormones and Infertility. Different factors affecting IVF pregnancy outcome. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 987. 57 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-8919-9. Various hormones have been studied as regards prediction of pregnancy outcome after infertility treatment, but no ideal candidate has been found. Folate and genetic variations in folate metabolism have also been associated with infertility, but it remains unclear how these factors affect IVF pregnancy outcome. It is known that infertility is associated with active folic acid supplement use, but the effect of socioeconomic and lifestyle factors on folic acid supplement use in infertile women has not been well investigated. The overall aim of this work was to obtain information on the prediction of live birth, and to study factors affecting the role of folate and folic acid intake in relation to IVF pregnancy outcome. Infertile women with various infertility diagnoses were studied. Healthy, fertile non-pregnant women were used as controls in three of the studies.
    [Show full text]
  • Success of Controlled Ovarian Hyperstimulation and Intrauterine Insemination in Couple with Unexplained Infertility
    J Women’s Health Dev 2020; 3 (2): 077-091 DOI: 10.26502/fjwhd.2644-28840019 Research Article Success of Controlled Ovarian Hyperstimulation and Intrauterine Insemination in couple with Unexplained Infertility Nazdar Raouf1*, Roj Hikmat², Aveen Munib³, Maida Shamdeen4, Ramadhan Salahaldeen5, Hameed Abdullah6 ¹Duhok Obstetrics and Gynecology Teaching Hospital, Kurdistan, Iraq ²Senior Registrar, Duhok Obstetrics and Gynecology Teaching Hospital, Kurdistan, Iraq ³Infertility and IVF center, College of Pharmcy, Azadi Teaching Hospital, Duhok, Iraq 4Obstetrics and Gynecology Department, Duhok Medical College, Azadi Teaching Hospital, Iraq 5Duhok Medical College, Azadi Teaching Hospital, Kurdistan, Iraq 6Neonatal Intensive Care Unit, Hevi Pediatrics Teaching Hospital, Duhok, Iraq *Corresponding Author: Nazdar Raouf, Duhok Obstetrics and Gynecology Teaching Hospital, Kurdistan, Iraq, Tel: + (964) 7504863598; Email: [email protected] Received: 05 April 2020; Accepted: 18 April 2020; Published: 23 April 2020 Citation: Nazdar Raouf, Roj Hikmat, Aveen Munib, Maida Shamdeen, Ramadhan Salahaldeen, Hameed Abdullah. Success of Controlled Ovarian Hyperstimulation and Intrauterine Insemination in couple with Unexplained Infertility. Journal of Women’s Health and Development 3 (2020): 077-091. Abstract Background: Management of unexplained infertility remains largely empirical, the therapeutic approach should be individualized taking into account patient age and duration of infertility, treatments include expectant observation with timed intercourse
    [Show full text]
  • Comparison of the Efficacy of Letrozole and Gonadotropin Combination Versus Gonadotropin Alone in Intrauterine Insemination Cycl
    ORIGINAL ARTICLE East J Med 25(3):427-433, 2020 DOI: 10.5505/ejm.2020.24993 Comparison of The Efficacy of Letrozole and Gonadotropin Combination Versus Gonadotropin Alone In Intrauterine Insemination Cycles In Patients With Unexplained Infertility Süleyman Cemil Oğlak1*, Mehmet Nafi Sakar2, Serhat Ege1, Serap Mutlu Özçelik Otçu1, Mehmet Obut3, Bekir Kahveci4, İsmail Yıldız5 1Health Sciences University, Diyarbakır Gazi Yaşargil Training and Research Hospital, Department of Obstetrics and Gynaecology, Diyarbakır, Turkey 2Memorial Diyarbakır Hospital, Department of Obstetrics and Gynecology, Diyarbakır, Turkey 3Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey 4Çukurova University School of Medicine, Department of Obstetrics and Gynaecology, Adana, Turkey 5Dicle University School of Medicine, Department of Biostatistics, Diyarbakır, Turkey ABSTRACT This study aimed to determine the outcomes of combined treatment of letrozole (LTZ) with recombinant follicle - stimulating hormone (rFSH) in comparison with rFSH alone in intrauterine insemination (IUI) cycles. This study consisted of 86 patients who experienced 106 IUI cycles. Patients were classified into two treatment groups: group I underwent a combination of LTZ plus rFSH, and group II received rFSH alone. Ovulation was triggered with human chorionic gonadotropin (hCG), and IUI performed 36 hours later. The number of follicles ≥18 mm, endometrial thickness, required dose of FSH, duration of ovulation induction (OI), clinical pregnancy rates, multiple pregnancy rates, spontaneous abortion rates, and live birth rates were evaluated. The total required rFSH dose during the OI was significantly lower in the LTZ-rFSH combination group than the rFSH alone group (401.2±177.1 IU and 770.1±345.8 IU, respectively, p<0.001).
    [Show full text]
  • Effects on Follicular Diameter and Endometrial Thickness in Polycystic Ovary Syndrome
    European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 07, 2020 Clomiphene Citrate and Anastrozole : Effects on Follicular Diameter and Endometrial Thickness in Polycystic Ovary Syndrome Yashinta Sampeliling1, Andi Mardiah Tahir2,Eddy Hartono3, Firdaus Kasim4 1,2,3Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Hasanuddin 4Faculty of Public Health, Universitas Hasanuddin, Dr. Wahidin Sudirohusodo General Hospital, Makassar Abstract Objective: To compare the effects of clomiphene citrate and anastrozole on follicular diameter and endometrial thickness in women with polycystic ovary syndrome (PCOS). Methods: This prospective study was conducted at the private-practice setting. The study group consisted of 14 patients who received clomiphene citrate 50 mg and 14 patients received anastrozole 1 mg on day 3 of menstruation for 5 days. Follicular diameter and endometrial thickness were measured with transvaginal ultrasound on day 12 of menstruation. Results: The mean diameter of follicles in the clomiphene citrate group was not significantly differ compared with anastrozole group (13.35±4.72 mm vs 10.92±4.29 mm; p>.05, respectively). A similar effect also observed in endometrial thickness for both study groups (8.51±1.88 mm in anastrozole vs 7.49±2.09 mm in clomiphene citrate; p>.05). Conclusion: Clomiphene citrate and anastrozole were not significantly improved follicular diameter dan endometrial thickness in polycystic ovary syndrome. Keywords : Clomiphene citrate, anastrozole, PCOS 1. INTRODUCTION Polycystic ovary syndrome (PCOS) occurs in 15-20% of reproductive women according to the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM). Fifty to seventy percents of PCOS cases are caused by insulin resistance.1 This syndrome is characterized by chronic anovulation with exaggerated biochemical and/or clinical of androgens and without other diseases of the adrenal gland, thyroid or pituitary in similar features.
    [Show full text]
  • Altered Follicular Fluid Metabolic Pattern Correlates with Female Infertility and Outcome Measures of in Vitro Fertilization
    International Journal of Molecular Sciences Article Altered Follicular Fluid Metabolic Pattern Correlates with Female Infertility and Outcome Measures of In Vitro Fertilization Giacomo Lazzarino 1,† , Romina Pallisco 2,†, Gabriele Bilotta 2,†, Ilaria Listorti 2,†, Renata Mangione 3,4, Miriam Wissam Saab 5, Giuseppe Caruso 6 , Angela Maria Amorini 5 , Maria Violetta Brundo 7 , Giuseppe Lazzarino 5,8,* , Barbara Tavazzi 3,4,* and Pasquale Bilotta 9 1 UniCamillus—Saint Camillus International University of Health Sciences, Via di Sant’Alessandro 8, 00131 Rome, Italy; [email protected] 2 Alma Res Fertility Center, Laboratory of Andrology and Embriology, Via Parenzo 12, 00198 Rome, Italy; [email protected] (R.P.); [email protected] (G.B.); [email protected] (I.L.) 3 Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of Rome, Largo F. Vito 1, 00168 Rome, Italy; [email protected] 4 Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy 5 Department of Biomedical and Biotechnological Sciences, Division of Medical Biochemistry, University of Catania, Viale A. Doria 6, 95125 Catania, Italy; [email protected] (M.W.S.); [email protected] (A.M.A.) 6 Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy; [email protected] 7 Department of Biology, Geology and Environmental Sciences, Section of Animal Biology, University of Catania, Via Androne 81, 95124 Catania,
    [Show full text]
  • Natural Cycle In-Vitro Fertilization in Couples with Unexplained Infertility: Impact of Various Factors on Outcome
    Human Reproduction vol.12 no.ll pp.2402-2407, 1997 Natural cycle in-vitro fertilization in couples with unexplained infertility: impact of various factors on outcome F.Zayed1'3, E.A.Lenton1'2 and I.D.Cooke2 The first live birth following IVF occurred in 1978 and was a consequence of IVF performed in the natural cycle 'Sheffield Fertility Centre, 26 Glen Road, Sheffield S7 IRA and 2University Department of Obstetrics and Gynaecology, of a woman with tubal infertility (Edwards et al, 1980). Downloaded from https://academic.oup.com/humrep/article/12/11/2402/664697 by guest on 30 September 2021 Jessop Hospital for Women, Sheffield S3 7RE, UK This success encouraged a number of groups to attempt NIVF, but they experienced difficulties (Johnston et al, 3To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Jordan University of Science and 1981; Jones et al, 1982). NIVF was quickly abandoned in Technology, P.O. Box 962106, Amman-11196, Jordan favour of stimulated IVF (SIVF), which yielded higher pregnancy rates as a consequence of transferring several This study evaluated outcome in 117 couples with un- embryos (Wood et al, 1985; Testart et al, 1986). However, explained infertility who underwent 162 attempts at recently interest in NIVF has revived because of concerns natural cycle in-vitro fertilization (NIVF) between 1991 surrounding ovarian stimulation. These include ovarian and 1993. An egg was obtained in 138 cycles and a hyperstimulation syndrome, multiple pregnancies (Rizk single embryo was transferred in 89 cycles. There were 16 et al, 1991; Tan et al, 1992), a possible decrease in implantations (four biochemical pregnancies, three clinical endometrial receptivity (Paulson et al, 1990), the emotional abortions and nine live births).
    [Show full text]
  • The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement
    The Optimal Evaluation of the Infertile Male: AUA Best Practice Statement Panel Members: AUA Staff: Jonathan Jarow, MD, Chairman Heddy Hubbard, PhD, MPH, FAAN, Mark Sigman, MD, Facilitator Cynthia Janus, MLS, Michael Folmer, Kebe Kadiatu Peter N. Kolettis, MD, Larry R. Lipshultz, MD, Consultant: R. Dale McClure, MD, Joan Hurley, JD, MHS Ajay K. Nangia, MD, Cathy Kim Naughton, MD, Gail S. Prins, PhD, Jay I. Sandlow, MD, Peter N. Schlegel, MD Table of Contents Abbreviations and Acronyms ...................................................................................................... 2 Introduction ................................................................................................................................... 3 Methodology .................................................................................................................................. 4 Evaluation goals ............................................................................................................................ 6 When to do a full evaluation for infertility ................................................................................. 7 Components of a full evaluation for male infertility .................................................................. 7 Required evaluation components for every patient ..................................................................... 7 Medical history ------------------------------------------------------------------------------------------ 7 Physical examination -----------------------------------------------------------------------------------
    [Show full text]
  • Unexplained Infertility
    Unexplained Infertility Kaylen M. Silverberg, M.D. Thomas C. Vaughn, M.D. Texas Fertility Center Austin, Texas Introduction Infertility is generally defined as the inability to conceive following one year of unprotected intercourse. This definition is often modified in couples where the female partner is 35 years of age or older, such that an infertility evaluation may be encouraged following only 6 months of unsuccessful attempted conception. Up to 30% of couples presenting with this chief complaint are eventually diagnosed as having unexplained infertility.1 Couples with unexplained infertility are thought to represent either a subpopulation of patients in the lower extreme end of the normal distribution of fertility, or a group of patients with a defect in fecundity not detected by the routine infertility evaluation.2 When compared to “normal, fertile” patients, couples with unexplained infertility demonstrate both diminished and delayed fecundity. Untreated, their pregnancy rates have been reported to be 34% within 6 months, 76% within 2 years, and 87% within 5 years.3 In a review of previously published prospective, randomized trials, Guzick et al determined the cycle fecundity rate with expectant management in couples with unexplained infertility to be 1.3-4.1% - compared to the generally accepted cycle fecundity of 20% in proven fertile couples. 4 This chapter will provide a critical, evidence based review of both the diagnosis and treatment of unexplained infertility. Diagnosis Traditionally, a diagnosis of unexplained infertility is made only when the basic infertility evaluation fails to reveal an obvious abnormality. This diagnosis therefore implies that a couple has evidence of normal, timely ovulation, adequate sperm production, fallopian tube patency, normal integrity of the endometrial cavity, adequate cervical mucus production, timely development of endometrial secretory change, and no evidence of pelvic endometriosis.
    [Show full text]